A Study to Evaluate Efficacy and Safety of IBI356 in Participants With Moderate to Severe Atopic Dermatitis
Clinical trial NCT07330934 · RECRUITING
Trial details
- NCT number
- NCT07330934
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-31
- Primary completion
- 2027-06-30
- Enrollment
- 403
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.